SISAQOL-IMI consortium publication: Interview with Madeline Pe (VIDEO)
Caption
The SISAQOL-IMI consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), just published its pivotal paper in The Lancet Oncology outlining how its recommendations for patient-reported outcomes (PROs) in cancer clinical trials were developed. Alongside the publication, the consortium has released a suite of accessible online materials designed to support researchers, clinicians, regulators, and policy makers in implementing these recommendations.
In this video interview, Dr Madeline Pe, Head of the EORTC Quality of Life Department and co-leader of the SISAQOL-IMI Management and coordination Work Package, tells us more about SISAQOL-IMI, how it came together and its outcomes.
More information: https://www.eortc.org/blog/2025/11/25/sisaqol-imi-consortium-publishes-key-paper-and-launches-online-materials/
Credit
European Organisation for Research and Treatment of Cancer (EORTC)
Usage Restrictions
/
License
Original content